32 results on '"Ottria, Andrea"'
Search Results
2. CXCL4 drives fibrosis by promoting several key cellular and molecular processes
3. Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis
4. Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis
5. Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c + Dendritic Cell Dysregulation in Systemic Sclerosis
6. CXCL4 drives fibrosis by promoting several key cellular and molecular processes
7. Impaired LAIR-1-mediated immune control due to collagen degradation in fibrosis
8. Endothelin Receptors Expressed by Immune Cells Are Involved in Modulation of Inflammation and in Fibrosis: Relevance to the Pathogenesis of Systemic Sclerosis
9. Nuclear Receptor Subfamily 4A Signaling as a Key Disease Pathway of CD1c+ Dendritic Cell Dysregulation in Systemic Sclerosis.
10. Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α
11. The role of hypoxia and metabolism in the pathogenesis of systemic sclerosis
12. Hypoxia and TLR9 activation drive CXCL4 production in systemic sclerosis plasmacytoid dendritic cells via mtROS and HIF-2α.
13. The role of hypoxia and metabolism in the pathogenesis of systemic sclerosis
14. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts
15. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis
16. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis
17. MTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout : A prelude to a new add-on therapy?
18. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis
19. Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic Sclerosis
20. MTOR inhibition by metformin impacts monosodium urate crystal-induced inflammation and cell death in gout: A prelude to a new add-on therapy?
21. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis
22. mTOR inhibition by metformin impacts monosodium urate crystal–induced inflammation and cell death in gout: a prelude to a new add-on therapy?
23. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
24. Hypoxia potentiates monocyte-derived dendritic cells for release of tumor necrosis factor α via MAP3K8
25. Hypoxia potentiates monocyte-derived dendritic cells for release of tumor necrosis factor α via MAP3K8
26. Modulation of adaptive immune response following intravenous immunoglobulin therapy in common variable immunodeficiency
27. Gene Expression Profiling in Peripheral Blood Cells and Synovial Membranes of Patients with Psoriatic Arthritis
28. Characterization of CD30/CD30L+Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis
29. Crossreactive Autoantibodies Directed against Cutaneous and Joint Antigens Are Present in Psoriatic Arthritis
30. Gene Expression Profiling in Peripheral Blood Mononuclear Cells of Patients with Common Variable Immunodeficiency: Modulation of Adaptive Immune Response following Intravenous Immunoglobulin Therapy
31. Characterization of CD30/CD30L+ Cells in Peripheral Blood and Synovial Fluid of Patients with Rheumatoid Arthritis.
32. Modulation of adaptive immune response following intravenous immunoglobulin therapy in common variable immunodeficiency.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.